Digital Health Startups

Locata builds software for primary care clinics to manage patient referrals and care coordination using AI, reducing administrative burden and improving care continuity. The platform helps clinics track patient journeys across the healthcare system and close gaps in care.

1 investor

Logibec (LGI Healthcare Solutions) develops software for healthcare organizations, including clinical, human capital, emergency, and financial management solutions such as staff scheduling and workforce operations. Its products serve hospitals and long-term care providers in the healthcare sector.

1 investor

Logical Health provides an AI-driven, two-way texting platform that conducts branded SMS, RCS, iMessage, and WhatsApp conversations with health plan members to identify and resolve barriers to care such as scheduling visits, explaining benefits, and arranging transportation. It serves healthcare organizations seeking to close care gaps and improve HEDIS and Star measure performance, integrating with existing member data and member-services systems.

1 investor

Logosoma operates speech therapy (logopädics) practices in Germany, handling administrative tasks and practice management so therapists can focus on patient care. The company aims to create a supportive work environment for speech therapists by centralizing scheduling, billing, and regulatory compliance.

1 investor

ロゴスサイエンス(Logos Science) develops Wemental®, a mental health self-care app built on cognitive behavioral science methods. The company applies research in applied brain science and cognitive behavioral science to make self-care systems accessible to users and usable by physicians across specialties.

1 investor

Lola Health provides group health insurance and wellbeing services for companies, with contracts partnered with AXA and a focus on women's health, parenthood, and mental health. It offers audits, health assessments, prevention actions, and a digital app for employers and members to manage coverage and claims, aimed at the French market.

1 investor

Longevity Health provides health insurance plans focused on optimizing quality of life for people in long-term care through value-based, personalized solutions addressing physical, mental, emotional, and social well-being.

1 investor

Longevity AI offers Florence AI, a clinical tool that analyzes patient data across cardiovascular, metabolic, cognitive, and immune systems, tracks patient trajectories between visits, and drafts clinical summaries, SOAP notes, and personalized care plans. It is built for clinical teams to deliver proactive, preventive care and can be adapted to each practice's protocols and standards.

1 investor

Loop Diagnostics develops an in vitro cellular immunoassay that detects immunosuppression from bloodstream infections, including sepsis, within the first hour of infection to enable earlier treatment. The company serves healthcare providers with a diagnostic tool for early sepsis detection.

1 investor

LoopedIn Health builds software for healthcare providers to manage patient onboarding, approvals, forms, and communications, aiming to reduce the time it takes patients to start or continue therapies. Its products are designed to integrate into existing clinical workflows.

1 investor

Loop Health offers daily diabetes management support delivered through a mobile app, assisted by a team of certified nutritionists. The service targets individuals in Indonesia managing diabetes.

1 investor

Louise builds AI infrastructure focused on human reproduction and medically assisted reproduction, aimed at supporting fertility patients and the clinics and systems that treat them. The company positions its product as "reproductive intelligence" for improving fertility treatment outcomes.

1 investor

Loyal provides a Care Activation Platform that enables health systems to deliver personalized patient engagement across the full care journey, from provider search and scheduling to outreach and follow-up, with integrated EHR connectivity and provider data management.

1 investor

Daopei is a group of specialty hospitals in China focused on blood diseases, offering hematopoietic stem cell transplantation, chemotherapy, immunotherapy (including CAR-T), and pathology/laboratory diagnostics for patients with leukemia, lymphoma, myeloma, and other hematological conditions. It operates multiple facilities in Beijing, Shanghai, and Hebei.

1 investor

LUBU makes smart insoles with built-in sensors that capture movement biomechanics and kinetic data to predict injury and track recovery for athletes, military personnel, and patients. The company uses proprietary hardware and AI-driven analysis, drawing on seventy years of footwear manufacturing expertise, to provide lab-grade movement measurement at scale.

1 investor

Luca develops LucaPlex, a modular SaaS platform combining digital biomarkers, AI algorithms, wearable devices, ePRO, and remote patient management to help life science companies and healthcare institutions build digital medicine products. The platform supports clinical trials, drug development, insurance and employee wellness programs by collecting continuous physiological and behavioral health data.

1 investor

Luca Health is a clinician-led platform for managing concussions in schools and sports clubs, covering the full process from logging an incident to a clinically supervised return to sport. It provides clinical review via secure video consultation, baseline neurocognitive testing, recovery tracking, documentation, and training modules, built around its evidence-based Luca Safe Concussion Framework and oriented to UK regulatory requirements.

1 investor

Lucea provides AI-powered triage software that pairs automation with clinical intelligence to support clinicians during pediatric triage calls, offering protocol-aligned context while clinicians retain clinical judgment. It is built for pediatric practices and their care teams, focusing on more efficient and consistent triage workflows.

1 investor

Lucem Health applies clinical artificial intelligence to help healthcare providers detect chronic diseases earlier in patients. The company develops AI-driven platforms for healthcare systems to improve disease detection and patient outcomes.

1 investor

Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring. Its liquid biopsy and tissue tests serve oncology patients and clinicians across multiple solid tumors and hematological cancers, available internationally and in the USA.

1 investor

Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer. The company operates a CLIA-certified, CAP-accredited clinical lab licensed by the New York State Department of Health.

1 investor

Lucid Genomics provides a software platform for genomic analysis tailored to clinicians, specializing in long-read sequencing interpretation for rare disease, hereditary cancer, and pharmacogenomics diagnostics. The platform integrates variant calling, prioritization, interpretation, and reporting with HPO-based phenotype matching and advanced visualization tools for structural variants.

1 investor

LucidHealth is a physician-led healthcare organization that supports a national network of radiology practices across the United States through corporate services including operations, finance, technology, and strategy. The company focuses on empowering radiologists and advancing clinical outcomes in radiology care.

1 investor

LumaBridge is an oncology-focused contract research organization (CRO) that supports outsourced clinical trials, offering services such as regulatory affairs, clinical operations, data management, medical writing, and biostatistics. It serves emerging biopharma and biotech companies developing novel oncology and immunotherapy treatments.

1 investor